Diagnostic Testing of STDs Market Size, Trends, Shares, Insights and Forecast – 2020-2027

1. DIAGNOSTIC TESTING OF STDS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Diagnostic Testing of STDs Market - Overview Various laboratory diagnostic tests for Sexually Transmitted Diseases (STDs) include, chlamydia diagnostic tests that include, Direct Fluorescent Antibody (DFA), Enzyme immunoassay (EIA), molecular-based diagnostic testing / DNA probes, Nucleic Acid Amplification Tests (NAATs), Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription Mediated Amplification (TMA), and Strand Displacement Assay (SDA). Statistics: The global Diagnostic Testing of STDS Market is estimated to account for US$ 290,128.2 Mn in terms of value by the end of 2027. Global Diagnostic Testing of STDs Market: Drivers Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. For instance, in November 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of Sentosa SQ HIV Genotyping Assay, a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. Increase in STDs awareness is expected to offer lucrative growth opportunities for players in the global diagnostic testing of STDs market. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/diagnostic-testing-of-stds-market-3917 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Diagnostic Testing of STDs Market: Restraints Large proportion of STD infected patients in out-of-reach geographic areas is expected to hinder growth of the market. It is observed that a large proportion STD infected patients and related / undetected cases are in out-of-reach geographic areas in many developing regions. The provision of infrastructure such as labs, equipment and supplies, trained laboratory experts or personnel proves uneconomic due to location constraints / deep difficult-to-reach areas. Lack of ease of accessibility and inadequate and unreliable infrastructure thus deters many from voluntary / Client-Initiated Counselling and Testing (CICT) diagnostic testing of STDs. Key Takeaways: The global diagnostic testing of STDs market was valued at US$ 140,028.5 Mn in 2019 and is forecast to reach a value of US$ 290,128.2 Mn by 2027 at a CAGR of 9.6% between 2020 and 2027. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. Chlamydia segment held dominant position in the global diagnostic testing of STDs market in 2019, accounting for 29.9% share in terms of value. Increasing incidence and prevalence of chlamydia in developing economies is expected to drive the segment growth during the forecast period. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3917 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, bioLytical Laboratories launched the INSTI HIV-1 / HIV-2 Antibody Test in Canada. North America is witnessing increasing adoption of STD testing. For instance, in May 2020, GoodRx, Inc. announced the GoodRx labs marketplace to offer 18 different tests by direct-to- consumer companies such as myLAB Box, Paloma Health and HeyDoctor by GoodRx for conditions such as allergies, coronavirus, diabetes, thyroid, cholesterol, urine analysis, STDs, fertility, and pregnancy. Global Diagnostic Testing of STDs Market: Competitive Landscape Major players operating in the global diagnostic testing of STDs market include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories. Global Diagnostic Testing of STDs Market: Key Developments August 2019: binx health received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its binx io, a molecular point-of-care diagnostic testing platform for the detection of chlamydia and gonorrhea Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3917 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved